The success of copyright’s blockbuster initially sparked a period of growth for major more info pharmaceutical companies, nevertheless recent developments present a uncertain picture for shareholders. Off-patent competitors are eating into earnings, and ongoing litigation add additional complexity to the situation. While specific companies might